Geneos Therapeutics
Latest round
- Series A
Last raised
- Sep 2023
Total raised
- $50M
Investors
- 6
About Geneos Therapeutics
Founded in 2017 and based in Pennsylvania, US, Geneos Therapeutics, Inc. operates as a developer of immunotherapies targeting neoantigens from tumors which serves as a treatment for cancer. The company was founded by its President and Chief Executive Officer Niranjan Y. Sardesai. In March 2023, Geneos Therapeutics, Inc. Geneos has a neoantigen-targeting platform called GT-EPIC™ that is based on a DNA medicines technology licensed from Inovio Pharmaceuticals, Inc. The GT-EPIC™ platform allows Geneos to identify relevant neoantigen targets from individual patient tumors to develop novel treatments for cancer. As of 2021, the company is pursuing three clinical pipeline programs: GT-10, GT-20, and GT-30. GT-10 is a clinical trial for Geneos’s neoantigen-targeted personalized vaccine, GNOS-PV02 for the treatment of a patient with anaplastic astrocytoma. GT-20 is a clinical trial in collaboration with Washington University to treat patients with newly diagnosed glioblastoma multiforme and GT-30 is a clinical trial to treat patients with hepatocellular carcinoma.
Who invested in Geneos Therapeutics
6 investors across 5 rounds
See all investors in Geneos Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Geneos Therapeutics
Who invested in Geneos Therapeutics?
Geneos Therapeutics has 6 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Geneos Therapeutics raised?
Geneos Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Geneos Therapeutics last raise money?
Geneos Therapeutics's most recent round on record is a Series A, in Sep 2023.
What does Geneos Therapeutics do?
Founded in 2017 and based in Pennsylvania, US, Geneos Therapeutics, Inc.
Where is Geneos Therapeutics headquartered?
Geneos Therapeutics is headquartered in US.
Which VCs invest in companies like Geneos Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Geneos Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Geneos Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.